ClinLabNavigator Logo
ANA
Available Documents
New Documents
ABO Blood Group System
Acute Hemolytic Transfusion Reaction
Allergic Reactions
Anaphylactic Reactions
Antibody Adsorption Procedures
Antibody Identification
Apheresis
Autologous Blood Donation
Blood Infusion
Blood Salvage
CMV Negative Blood Components
Compatibility Testing
Cord Blood Direct Antiglobulin Testing
Cryoprecipitate
Delayed Hemolytic Transfusion Reaction
Direct Antiglobulin Test
Directed Blood Donations
Drug Induced Thrombocytopenia
Febrile Nonhemolytic Reactions
Fetal Maternal Hemorrhage
Hemophilia A
Hemophilia B
Heparin Induced Thrombocyopenia
Previous Documents
ABO Blood Group System
ABO Mismatched Allogeneic Transplants
Albumin
Autoimmune Hemolytic Guidelines
Blood Administration
Blood Component Transfusion Guidelines
Blood Donation
CMV Negative Blood Components
Compatibility Testing
Cryoprecipitate
Factor IX Complex
Factor VIIa
Factor VIII Concentrate
Factor VIII Inhibitors
Fresh Frozen Plasma
Granulocyte Transfusion
Hemolysis Following Allogeneic BMT
Informed Consent
Irradiated Blood Components
Leukocyte Reduced Red Cells & Platelets
Massive Transfusion
Neonatal Alloimmune Thrombocytopenia
Nitric Oxide Banked Blood
Other Blood Group Systems
Pediatric & Neonatal Transfusion Practices
Platelet Transfusion
Prenatal & Perinatal Immunohematologic Testing
RBC Transfusion Trigger
Red Blood Cell Transfusion
Rh Blood Group System
RhIG for HDN Prevention
RhIG for Treatment of ITP
Saline Washed Red Blood Cells
Sickle Cell Disease Transfusion
Therapeutic Apheresis
Thrombotic Thrombocytopenic Purpura
Transfusion Reactions
Transfusion Related Acute Lung Injury
Trypanosoma Cruzi Donor Screening
Umbilical Cord Blood Stem Cells
von Willebrands Disease
Warm Autoimmune Hemolytic Anemia
Transfusion

Apheresis

Print This Page
E-mail This Page

Apheresis employs an automated cell separator that harvests a specific blood component by centrifugal force. It involves a multi-step process that includes:
  • Removal of whole blood from a donor or patient
  • Separation of whole blood into components such as red cells, plasma, platelets or white cells
  • Retention of the specific component needed
  • Return of the unneeded recombined components to the donor


Apheresis takes 1 to 2 hours to complete. During this time the donor or patient is connected by 1 or 2 IV lines to a sterile set of collecting and infusion bags. This closed system eliminates the risks of bacterial contamination and of returning the wrong blood to the donor.

Red cells may be collected by apheresis. Two allogeneic or autologous red cell units may be removed every 16 weeks. Volume depletion is minimized with saline infusion and the procedure is limited to individuals who are larger and have higher hematocrits (>40%) than current minimum standards for whole blood donors.

Plasmapheresis involves the separation of fresh plasma from 1.0 to 1.2 L of whole blood from a single donor, depending on the donor's weight. This component is usually processed into Fresh Frozen Plasma or Cryoprecipitate. Its larger volume (usually equivalent to 2 units FFP) can be used by one patient to reduce donor exposures or can be aliquoted to benefit several patients.



Plateletpheresis is the collection of platelets from a single donor and is often called single donor platelets. Donors should not take aspirin within 36 hours of donation. Blood pumped from one arm passes through a blood cell separator centrifugation system that collects platelets and returns plasma and red cells to the donor's other arm. Between 4000 and 5000 mL of blood are processed over 1.5 to 2 hours. A single donor platelet concentrate contains >3.0 X 1011 platelets suspended in approximately 200 mL of plasma, which is the equivalent of 6 to 8 random donor platelet concentrates. They can be stored up to 5 days at room temperature.

Because red cells and plasma are returned, a plateletpheresis donor can give more frequently than a whole blood donor; once or twice a week. This procedure is ideal for collecting platelets from special donors such as directed donor, platelet crossmatch compatible or HLA-matched.

Single donor apheresis platelets contain fewer than 5 x 106 white blood cells and are considered to be leukocyte reduced. Additional leukocyte reduction filtration is not necessary. Rh negative patients do not need Rh immune globulin after transfusion of Rh positive apheresis platelets because they contain so few red blood cells.